Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans-Pacific Partnership (TPP) trade agreement. Support domestic and international corporate tax policies which protect and incentivize US-based research and manufacturing jobs. Support for reauthorization of the Prescription Drug User Fee Act (PDUFA V) to:
1) Improve the transparency and predictability of the FDA drug review process.
2) Allow for modifications to the REMS program to improve communication and accuracy of information to providers and patients.
3) Expand existing FDA authority to allow for accelerated approval for products that address severe and life threatening diseases.
MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committe)
Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committe